BNP Paribas SA (BNPQY)

Oncternal Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	11,399	11,688	10,975	9,848	9,488	7,067
Depreciation & Amortization	7,702	7,272	6,245	6,465	6,781	6,325
Total Asset Writedown	30	21	-32	91	22	24
Change in Income Taxes	-3,738	-3,133	-3,359	-1,999	-2,356	-2,589
Change in Other Net Operating Assets	-6,359	-121,525	-54,760	-86,713	4,759	126,350
Other Operating Activities	9,990	9,002	3,625	19,303	23,283	2,085
Net Cash from Discontinued Operations	-	-	3,658	823	893	485
Operating Cash Flow	18,288	-97,376	-34,241	-52,837	42,376	139,324
Operating Cash Flow Growth	-	-	-	-	-69.58%	-
Capital Expenditures	-2,216	-2,136	-2,216	-2,529	-1,664	-773
Investment in Securities	-	-	-	-	-	-78
Income (Loss) Equity Investments	-736	-701	-593	-655	-494	-423
Divestitures	-71	1,956	9,520	366	482	-
Investing Cash Flow	-2,287	-180	7,304	-2,163	-1,182	-851
Issuance of Common Stock	181	388	1,668	5,020	1,235	1,615
Repurchase of Common Stock	-805	-2,439	-5,221	-2,862	-2,691	-340
Common Dividends Paid	-5,198	-5,198	-4,744	-4,527	-3,323	-
Preferred Dividends Paid	-743	-743	-654	-374	-412	-426
Total Dividends Paid	-5,941	-5,941	-5,398	-4,901	-3,735	-426
Other Financing Activities	8,581	1,574	4,275	11,993	19,707	17,675
Financing Cash Flow	2,016	-6,418	-4,676	9,250	14,516	18,524
Foreign Exchange Rate Adjustments	-3,612	-393	-3,506	1,030	107	-2,614
Net Cash Flow	14,405	-104,367	-35,119	-44,720	55,817	154,383
Free Cash Flow	16,072	-99,512	-36,457	-55,366	40,712	138,551
Free Cash Flow Growth	-	-	-	-	-70.62%	-
Free Cash Flow Margin	34.72%	-217.57%	-85.13%	-130.36%	97.81%	370.32%
Free Cash Flow Per Share	14.26	-87.81	-30.37	-44.90	32.65	111.03
Cash Income Tax Paid	3,738	3,133	3,359	1,999	2,356	2,589

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.